ABSTRACT Constitutive expression of α1-antitrypsin (α1AT), a serine protease inhibitor, by a recombinant simian virus-40-based vector blocks both HIV gp160 and p55 processing, and so is a

powerful inhibitor of HIV replication. To apply these findings more effectively in devising HIV therapies, we tested HIV LTR conditional promoter, to drive the expression of α1AT.

SV[LTR](AT) was designed so that synthesis of human α1AT would be _trans_-activated by HIV infection. Cell lines and primary human lymphocytes were transduced with SV[LTR](AT) without

selection and detectable toxicity. Responsiveness of α1AT expression to HIV Tat or HIV challenge was confirmed by Northern blotting, RT-PCR, cytofluorimetry and immunostaining.

effective anti-HIV therapeutic may be an effective approach to gene therapy of HIV replication. Access through your institution Buy or subscribe This is a preview of subscription content,

access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 6 print issues and online access $259.00 per year only $43.17 per issue Learn

more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS

OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS HIV-2 VPX NEUTRALIZES HOST RESTRICTION FACTOR

SAMHD1 TO PROMOTE VIRAL PATHOGENESIS Article Open access 25 October 2021 INFLUENCE OF AAV VECTOR TROPISM ON LONG-TERM EXPRESSION AND FC-Γ RECEPTOR BINDING OF AN ANTIBODY TARGETING SARS-COV-2

Article Open access 16 July 2024 IGG-CLEAVAGE PROTEIN ALLOWS THERAPEUTIC AAV GENE DELIVERY IN PASSIVELY IMMUNIZED MPS IIIA MICE Article 17 October 2022 REFERENCES * Mccune JM et al.

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. _Cell_ 1988; 53: 55–67. Article  CAS  Google Scholar  * Kohl NE et al. Active human

immunodeficiency virus protease is required for viral infectivity. _Proc Natl Acad Sci USA_ 1988; 85: 4686–4690. Article  CAS  Google Scholar  * Kurachi K et al. Cloning, sequence of cDNA

coding for alpha 1-antitrypsin. _Proc Natl Acad Sci USA_ 1981; 78: 6826–6830. Article  CAS  Google Scholar  * Cordelier P, Zern MA, Strayer DS . HIV-1 proprotein processing as a target for

gene therapy. _Gene Therapy_ 2003; 10: 467–477. Article  CAS  Google Scholar  * Strayer DS . SV40 as an effective gene transfer vector _in vivo_. _J Biol Chem_ 1996; 271: 24741–24746. CAS 

Google Scholar  * Strayer DS, Milano J . SV40 mediates stable gene transfer _in vivo_. _Gene Therapy_ 1996; 3: 581–587. CAS  Google Scholar  * Strayer DS, Zern MA . Gene delivery to the

liver using simian virus 40-derived vectors. _Semin Liver Dis_ 1999; 19: 71–81. Article  CAS  Google Scholar  * Strayer DS . Effective gene transfer using viral vectors based on SV40.

_Methods Mol Biol_ 2000; 133: 61–74. CAS  PubMed  Google Scholar  * Zern MA et al. A novel SV40-based vector successfully transduces, expresses an alpha 1-antitrypsin ribozyme in a human

hepatoma-derived cell line. _Gene Therapy_ 1999; 6: 114–120. Article  CAS  Google Scholar  * Gordon VM et al. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by

furin, by additional cellular proteases. _Infect Immun_ 1995; 63: 82–87. CAS  PubMed  PubMed Central  Google Scholar  * Hallenberger S et al. The role of eukaryotic subtilisin-like

endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. _J Virol_ 1997; 71: 1036–1045. CAS  PubMed  PubMed Central  Google Scholar  * Moulard M,

Decroly E . Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. _Biochim Biophys Acta_ 2000; 1469: 121–132. Article  CAS  Google Scholar  * Strayer DS et al.

Titering replication-defective virus for use in gene transfer. _Biotechniques_ 1997; 22: 447–450. Article  CAS  Google Scholar  * Strayer DS et al. Generation of recombinant SV40 vectors for

gene transfer. _Methods Mol Biol_ 2001; 165: 103–117. CAS  PubMed  Google Scholar  * Kondo R, Feitelson MA, Strayer DS . Use of SV40 to immunize against hepatitis B surface antigen:

implications for the use of SV40 for gene transduction, its use as an immunizing agent. _Gene Therapy_ 1998; 5: 575–582. Article  CAS  Google Scholar  * Sauter BV et al. A

replication-deficient rSV40 mediates liver-directed gene transfer, a long-term amelioration of jaundice in Gunn rats. _Gastroenterology_ 2000; 119: 1348–1357. Article  CAS  Google Scholar 

Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Pathology, Jefferson Medical College, Philadelphia, PA, USA P Cordelier & D S Strayer Authors * P

Cordelier View author publications You can also search for this author inPubMed Google Scholar * D S Strayer View author publications You can also search for this author inPubMed Google

Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Cordelier, P., Strayer, D. Conditional expression of α1-antitrypsin delivered by recombinant SV40

vectors protects lymphocytes against HIV. _Gene Ther_ 10, 2153–2156 (2003). https://doi.org/10.1038/sj.gt.3302113 Download citation * Received: 08 January 2003 * Accepted: 09 May 2003 *

Published: 17 November 2003 * Issue Date: 01 December 2003 * DOI: https://doi.org/10.1038/sj.gt.3302113 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this

content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

KEYWORDS * α1-antitrypsin * SV40 * conditional promoter